K213049 is an FDA 510(k) clearance for the STIMPOD NMS450 Nerve Stimulator. This device is classified as a Stimulator, Nerve, Battery-powered (Class II - Special Controls, product code BXN).
Submitted by Xavant Technology (Pty), Ltd. (Pretoria, ZA). The FDA issued a Cleared decision on October 16, 2022, 389 days after receiving the submission on September 22, 2021.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.2775.
| 510(k) Number | K213049 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 22, 2021 |
| Decision Date | October 16, 2022 |
| Days to Decision | 389 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | BXN - Stimulator, Nerve, Battery-powered |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 868.2775 |